Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT03761875

NK Cell Deregulation in HBV Patients

Conditions: Hepatitis B Virus

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: NA
Enrollment: 80
Sponsor: University Hospital, Limoges

Location: Limoges Hospital Limoges

Summary

Natural Killer (NK) cells play a large role in the innate immune response as they are equipped to kill infected or tumor cells. They express a panel of activating and inhibitory receptors that regulate the destruction of the target cell. Many reports have shown that NK cell function is suppressed in CHB patients. Exhaustion occurs when activating receptors become over stimulated leading to the loss of NK function. The investigators hypothesize that NK cells are rendered dysfunctional/ exhausted by HBV. The primary objective is to determined the phenotypical modifications and mechanisms associated to NK cell dysfunction, during different phases of CHB infection, in not treated patients.

Eligibility Criteria

Inclusion Criteria: Patients must meet all of the following inclusion criteria to be eligible for participation in this study: * Male or female, age ≥18 years * HBV infection or chronic HBV infection * Willing and able to provide written informed consent Healthy donors must meet all of the following inclusion criteria to be eligible for participation in this study: * Male or female, age between 18 and 50 years * Willing and able to provide written informed consent Exclusion Criteria: * Subjects who meet any of the following exclusion criteria are not to be enrolled in this study: * Infection with hepatitis C virus (HCV) or human immunodeficiency virus (HIV) * Chronic liver disease of a non-HBV etiology * Immune or cancerous disease

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT03761875). StuddyBuddy aggregates publicly available trial information.